Seattle biotech startup Curi Bio lands $10M to expand its R&D support for drug discovery Seattle biotech startup Curi Bio today announced $10 million in new funding. The company enables the screening of new drugs using 3D tissue models. Read More
Curi Bio raises $10M for stem-cell based drug discovery platforms Seattle-based startup Curi Bio has raised $10 million to advance its platforms for drug discovery, based on human stem cells.… Read More
Tech Moves: Startup Haven grows team to lead new fund; PSL promotions; F5 Networks adds execs — Startup Haven, a community for entrepreneurs founded by Seattle startup vet Bob Crimmins, launched an investment fund called Startup… Read More
